GLP-1s have a plethora of benefits ranging from reducing inflammation, to stimulating the immune system, to reducing oxidative stress, to boosting mitochondrial function, that lead to documented neurocognitive and cardiovascular protection
doi:10.1038/nrn3104 148
Luminal A is the most common molecular subtype of breast cancer, accounting for approximately 50% of invasive breast cancer cases [2], and is characterized as estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), HER2/Neu-negative, with low Ki-67 expression [3]
Obesity can also trigger other symptoms like hormone imbalance, insomnia, and gut issues
The addition of Retatrutide, which improves insulin sensitivity through GLP-1 and GIP pathways, likely offsets any mild glucose-raising effect from Tesamorelin
GHK-Cu Dosage Recommendation As a research peptide, there is no recommended dose for GHK-Cu